Active Shortage

NAT-ERLOTINIB

NATCO PHARMA (CANADA) INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of NAT-ERLOTINIB in Canada?

Yes. NAT-ERLOTINIB 150MG has an active shortage reported to Health Canada (last updated April 13, 2026).

When will NAT-ERLOTINIB be available again?

The manufacturer's estimated resolution date is June 30, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Expected resolution~8 months remaining (estimate)

Affected strength150MG

Report last updated2026-04-13

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

TEVA-ERLOTINIB

TEVA CANADA LIMITED

150MG · DIN 02377713

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

APO-ERLOTINIB

APOTEX INC

25MG · DIN 02461862

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02483939

Strength

150MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ERLOTINIB

See all ERLOTINIB products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-04-13

Active Shortage

Other (Please describe in comments)

Other Products from NATCO PHARMA (CANADA) INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

250MG · DIN 02494132

1MG · DIN 02417855

5MG · DIN 02492822

2.5MG · DIN 02492814

100MG · DIN 02496895

25MG · DIN 02496887